Kishor Devalaraja-Narashimha is a prominent inventor based in Yorktown Heights, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-C5 antibody combinations. With a total of 3 patents to his name, his work has the potential to impact therapeutic methods significantly.

Latest Patents

His latest patents focus on anti-C5 antibody combinations and their uses. The inventions relate to combinations of anti-C5 antibodies and antigen-binding fragments that exhibit superior activity compared to single anti-C5 antibodies or fragments. These combinations include antibodies and fragments that do not compete for C5 binding. Additionally, his patents provide bispecific antibodies comprising antigen-binding domains that do not compete or bind the same epitope on C5. The compositions and therapeutic methods associated with these anti-C5 combinations and bispecific antibodies are crucial advancements in the field.

Career Highlights

Kishor is currently associated with Regeneron Pharmaceuticals, Inc., where he continues to innovate and contribute to the advancement of medical science. His work at Regeneron has positioned him as a key player in the development of novel therapeutic solutions.

Collaborations

He collaborates with notable colleagues, including Lori C Morton and Yifan Luo, enhancing the research and development efforts within his team.

Conclusion

Kishor Devalaraja-Narashimha's contributions to the field of anti-C5 antibody research exemplify the impact of innovative thinking in biotechnology. His patents and ongoing work at Regeneron Pharmaceuticals, Inc. highlight the importance of collaboration and creativity in advancing medical therapies.

This text is generated by artificial intelligence and may not be accurate.